Related Experiment Videos

Screening for hearing loss in an at-risk neonatal population using evoked otoacoustic emissions

R Meredith1, D Stephens, S Hogan

  • 1Welsh Hearing Institute, University Hospital of Wales, Cardiff, UK.

Scandinavian Audiology
|January 1, 1994
PubMed

Insights

This 5-year study evaluated a neonatal hearing screening program using transient evoked otoacoustic emissions. While effective in detecting hearing loss without false negatives, it showed a high false positive rate, particularly in low birthweight infants.

Area of Science:

  • Audiology
  • Neonatal care
  • Public health

Background:

  • Neonatal hearing loss affects 1-3 per 1000 live births.
  • Early detection and intervention are crucial for language development.
  • Risk factors necessitate targeted screening programs.

Purpose of the Study:

  • To evaluate the 5-year performance of a neonatal hearing screening program.
  • To assess the effectiveness of transient evoked otoacoustic emissions (TEOAEs) in high-risk neonates.
  • To identify challenges and areas for improvement in the screening process.

Main Methods:

  • A 5-year prospective study involving 772 high-risk neonates.
  • Utilized the Programmable Otoacoustic Emissions Measurement System (POEMS).
  • Screening focused on transient evoked otoacoustic emissions (TEOAEs).

Main Results:

  • Successfully identified 14 cases of significant hearing loss.
  • Achieved zero false negative results, ensuring no true cases were missed.
  • Reported a high false positive rate, particularly in infants with birthweights under 1500g.

Conclusions:

  • TEOAE screening is effective in detecting neonatal hearing loss with high sensitivity.
  • The high false positive rate requires further investigation and potential refinement of screening protocols.
  • Optimizing screening for low birthweight infants is essential for program efficiency.

Related Concept Videos